智慧樹 WT 深 滬
等待開盤 10-09 09:30:00 美东时间
22.68
-0.690
-2.95%
華盛通- 最 高23.24
- 今 開23.13
- 成交量 81.76万股
- 最 低 22.66
- 昨 收 23.37
- 總市值 34.36亿
- 52周最高 25.91
- 市盈率 靜 30.33
- 換手率 0.54%
- 52周最低 10.60
- 委 比 -29.38%
- 總股本 1.52亿
- 歷史最高 25.91
- 量 比 0.57
- 振 幅 2.48%
- 歷史最低 1.09
- 每 手 1
- 風險率 4.04%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多QUICK SPARK: WisdomTree Launches AI-Powered ETFs Targeting Small Caps, Global Stocks
WisdomTree (NYSE:WT) launched two new ETFs on the Texas Stock Exchange, expanding its systematic long/short lineup. The WisdomTree Efficient Long/Short U.S. SmallCap Equity Fund (WSLS) targets U.S. small-cap stocks, combining broad small-cap exposure with a dynamic long/short overlay. The WisdomTree...
10-08 21:35
美股大行评级 | 潜在涨幅405.62%！Inventiva(IVA)获Truist Securities上调目标价至18美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持Inventiva"买入"评级，目标价从13美元升至18美元；富瑞：维持Sagimet Biosciences"买入"评级，目标价从25美元升至26美元
10-05 16:26
Goldman Sachs Maintains Neutral on WisdomTree, Raises Price Target to $21.3
Goldman Sachs analyst Alexander Blostein maintains WisdomTree (NYSE:WT) with a Neutral and raises the price target from $18.3 to $21.3.
10-03 01:12
美股大行评级 | Meta获4家机构看好！目标价最高升至950美元；好市多绩后齐遭机构降低目标价
今日重点评级关注：古根海姆：维持Damora Therapeutics"买入"评级，目标价从40美元升至60美元；HC Wainwright & Co.：维持Rezolute"买入"评级，目标价从5美元升至10美元
09-28 12:37
Morgan Stanley Maintains Equal-Weight on WisdomTree, Raises Price Target to $27
Morgan Stanley analyst Michael Cyprys maintains WisdomTree (NYSE:WT) with a Equal-Weight and raises the price target from $21 to $27.
09-25 21:43
WisdomTree And MoonPay Announce Strategic Collaboration To Make WisdomTree Treasury Money Market Digital Fund More Accessible To Everyday Investors In US Via MoonPay.
WisdomTree plans to provide eligible U.S. investors with another way to invest in WTGXX, supported by MoonPay’s technology and network of more than 35 million accounts. WisdomTree, Inc. (NYSE:WT), a global financial innovator, and MoonPay, the global financial technology company powering the movemen...
09-17 19:07
美股大行评级 | 潜在涨幅1610.53%！Ascendiant Capital上调Alzamend Neuro目标价至26美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Alzamend Neuro"买入"评级，目标价从25美元升至26美元；Tigress Financial：维持Legence"买入"评级，目标价从125美元升至130美元
08-20 08:39
Northland Capital Markets Maintains Outperform on WisdomTree, Raises Price Target to $26
Northland Capital Markets analyst Mike Grondahl maintains WisdomTree (NYSE:WT) with a Outperform and raises the price target from $22 to $26.
08-20 02:00
财报速睇 | 智慧树 2026财年Q2营收1.77亿美元，同比增长57.3%；归母净利润0.44亿美元，同比增长78.7%
华盛资讯8月6日讯，智慧树公布2026财年Q2业绩，公司Q2营收1.77亿美元，同比增长57.3%，归母净利润0.44亿美元，同比增长78.7%。
08-06 07:32
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
